XYMOGEN Omega MonoPure MD EC
Natural health product licensed in Canada
- Licence holder
- Xymogen
- NPN or DIN-HM
- 80071655
- Status
- Active licence
- Licence date
- 4 August 2016
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de poisson Source : Engraulidae - en entier Potency : 100 mg Docosahexaenoic acid | 500 mg | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 100 mg Docosahexaenoic acid | 500 mg | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 330 mg Omega-3 Fatty acids | Not specified | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 330 mg Omega-3 Fatty acids | Not specified | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 230 mg Eicosapentaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 230 mg Eicosapentaenoic acid | Not specified | Not calculated |
| Olea europaea Source : Olea europaea - feuille Extract : Matériel brut frais Extraction ratio : 9:1 Dry plant equivalent : 90 mg Potency : 4 % Oleuropein | 10 mg | Not calculated |
| Olea europaea Source : Fruit Extract : Matériel brut frais Extraction ratio : 400:1 Dry plant equivalent : 16 g Potency : 9 % 3,4-Dihydroxyphenylethanol | 40 mg | Not calculated |
Non-medicinal ingredients
NA, Gélatine, Acide stéarique, Cire d'abeille, Maltodextrine, Hydroxyde d'ammonium, Lécithine, Mélange de concentré de tocophérol, Acide oléique, Eau purifiée, Éthylcellulose, Alginate de sodium, Silice, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of omega-3 fatty acids for the maintenance of good health. Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Helps support cognitive health and/or brain function. Source of antioxidant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult your healthcare practitioner prior to use if you are pregnant or breastfeeding, taking other diuretics or blood thinners or if you have a kidney disorder. Do not use if tamper seal is damaged.
Source
Official Health Canada record, licence 80071655
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.